9490 NEOGENOMICS WAY, FORT MYERS, FL
Appoints Carolyn Starrett to its Board of Directors
NeoGenomics Completes $316.25 Million Convertible Notes Offering
Announces Pricing of Offering of $275 Million Convertible Senior Notes
Announces Proposed Offering of $275 Million Convertible Senior Notes
Reports First Quarter 2026 Results
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Results
Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Prospectus filed pursuant to Rule 424(b)(7)